John Munkhagen

 John Munkhaugen 

Education

  • PhD (2008-2010), Faculty of Medicine, Norwegian University of Technology and Science
  • MD (2002-2008), Faculty of Medicine, Norwegian University of Technology and Science

Work record (selected)

  • Head of research (2019-), Department of Medicine, Vestre Viken Trust, Drammen Hospital
  • Professor II (2023-), Institute of Basic Sciences in Medicine, University of Oslo
  • Cardiologist trainee (2020-2022), Oslo University Hospital Ullevål
  • Consultant (const.) (2015-2020), Department of Medicine, Vestre Viken Trust, Drammen Hospital
  • Trainee in internal medicine (2010-2015), Dept. of Behavioural Medicine,  University of Oslo
  • Postdoc and lecture (2012-2018), Dept of Behavioural Medicine,  University of Oslo

Awards, committees, memberships

  • Professional member European Society of Cardiology (ESC), European Association for Preventive -Cardiology (EAPC), Norwegian Society of Cardiology 
  • Several international and national awards, incl. Young Investigator Award (YIA) at the European Society of Cardiology (ESC; 2023).
  • Selected/elected member of several research committees, incl. Young Ambassador to the European Association  of Preventive Cardiology (EAPC) (2020-), Cardiovascular Board of Nasjonalforeningen (2021- ), advisory board and special commitees on behalf of the Norwegian Medicines Agency and the Ministry of Healthcare Services (2022) and the Directorate of Health (several times), co-chair for the Task Force group in preventive cardiology « NCS AG Preventiv” 

Other

  • In total, received ~4 mill Euro in funding to the NORCOR research group since 2015 incl. 6 postdoc and 7 PhD fellowships from HSØ, Norwegian Research Council, National Health Association, Dam Foundation
  • Teaching, examination, supervision and mentoring activities since 2014 incl. 5 PhD candidates and 2 post-docs . 
  • International Reviewer for several journals including: Journals of the American College of Cardiology (JACC), Cell Metablism, Eur J Preventive Cardiololgy, Eur J Respiratory Medicine, Journal of Internal Medicine, American Heart Journal, and Heart
  • Broad research communication at meetings and conferences, and public outreach as elaborated on norcor.no . 
  • Co-chair for the bi-national trial: “BETAMI-DANBLOCK trial”. Received ~>2mill Euro in funding.
  • Participating as partner on a EU Horizon 2024 application 

Research Areas

  • Preventive cardiology
  • Behavioural medicine
  • Clinical pharmacology
  • Cardiac intervention studies
  • Heart failure